GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Beneish M-Score

Biovica International AB (OSTO:BIOVIC B) Beneish M-Score : -1.93 (As of May. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.93 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Biovica International AB's Beneish M-Score or its related term are showing as below:

OSTO:BIOVIC B' s Beneish M-Score Range Over the Past 10 Years
Min: -3.94   Med: -1.9   Max: 393.86
Current: -1.93

During the past 9 years, the highest Beneish M-Score of Biovica International AB was 393.86. The lowest was -3.94. And the median was -1.90.


Biovica International AB Beneish M-Score Historical Data

The historical data trend for Biovica International AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Beneish M-Score Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.26 -3.94 -1.90 -1.65 -2.30

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -2.30 -1.32 -1.60 -1.93

Competitive Comparison of Biovica International AB's Beneish M-Score

For the Biotechnology subindustry, Biovica International AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Beneish M-Score falls into.



Biovica International AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Biovica International AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6032+0.528 * 1.2+0.404 * 1.1502+0.892 * 1.8054+0.115 * 0.7767
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.024829-0.327 * 1.0127
=-1.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jan24) TTM:Last Year (Jan23) TTM:
Total Receivables was kr5.14 Mil.
Revenue was 1.075 + 2.563 + 1.754 + 0.952 = kr6.34 Mil.
Gross Profit was 0.772 + 2.645 + 2.209 + 1.57 = kr7.20 Mil.
Total Current Assets was kr113.01 Mil.
Total Assets was kr158.32 Mil.
Property, Plant and Equipment(Net PPE) was kr8.63 Mil.
Depreciation, Depletion and Amortization(DDA) was kr9.07 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr15.54 Mil.
Long-Term Debt & Capital Lease Obligation was kr4.80 Mil.
Net Income was -27.343 + -25.684 + -32.264 + -37.699 = kr-122.99 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.00 Mil.
Cash Flow from Operations was -22.76 + -28.337 + -38.227 + -29.735 = kr-119.06 Mil.
Total Receivables was kr4.72 Mil.
Revenue was 0.926 + 0.961 + 0.545 + 1.082 = kr3.51 Mil.
Gross Profit was 1.061 + 1.118 + 0.868 + 1.736 = kr4.78 Mil.
Total Current Assets was kr151.18 Mil.
Total Assets was kr204.52 Mil.
Property, Plant and Equipment(Net PPE) was kr12.13 Mil.
Depreciation, Depletion and Amortization(DDA) was kr8.02 Mil.
Selling, General, & Admin. Expense(SGA) was kr16.11 Mil.
Total Current Liabilities was kr17.95 Mil.
Long-Term Debt & Capital Lease Obligation was kr7.99 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.135 / 6.344) / (4.715 / 3.514)
=0.809426 / 1.341776
=0.6032

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4.783 / 3.514) / (7.196 / 6.344)
=1.361127 / 1.1343
=1.2

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (113.006 + 8.625) / 158.32) / (1 - (151.182 + 12.128) / 204.515)
=0.23174 / 0.201477
=1.1502

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6.344 / 3.514
=1.8054

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(8.019 / (8.019 + 12.128)) / (9.066 / (9.066 + 8.625))
=0.398025 / 0.512464
=0.7767

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 6.344) / (16.114 / 3.514)
=0 / 4.585657
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4.802 + 15.535) / 158.32) / ((7.993 + 17.949) / 204.515)
=0.128455 / 0.126846
=1.0127

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-122.99 - 0 - -119.059) / 158.32
=-0.024829

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Biovica International AB has a M-score of -1.93 suggests that the company is unlikely to be a manipulator.


Biovica International AB Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines